its a poorly managed company that has a product several years away from marketing. As mentioned it failed to find a joint partner, decided to waive a 500K royalty from BEL that it was due(can you believe it) the new MD Zwolenski was manager fro Roche diagnostics considered very marginal by Roche as he had no lateral thinking seems to have reduced cash burn but still not enough and product development has been pathetically slow. We are talking about a simple diagnostics instrumnet folks something you make in your home workshop! As for cash burn still got over 30 employess o the payroll and $9.5 M in the bank half what it had a year ago. Do your own research these are only my opinions. Be carefull
ABI Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
